Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Gynecologic Oncology|February 24, 2021
Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancerArnaud Da Cruz Paula, Deborah F DeLair, Lorenzo Ferrando, et al.Journal of the National Cancer Institute|April 5, 2017
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and RecurrenceTheodore M Brasky, Ashley S Felix, David E Cohn, et al.Gynecologic Oncology|October 17, 2022
Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic driversSarah Ehmann, Dib Sassine, Alli M Straubhar, et al.Gynecologic Oncology|April 25, 2025
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeuticsKari L Ring, Anne M Mills, Brooke E Howitt, et al.Gynecologic Oncology|November 28, 2022
Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN projectLukáš Dostálek, Klára Benešová, Jaroslav Klát, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 22, 2017
Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract CarcinosarcomasAnkur R Sangoi, Malti Kshirsagar, Andres A Roma, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2021
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibitionSarah Chiang, Varshini Vasudevaraja, Jonathan Serrano, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 29, 2019
Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar CancerKim E Kortekaas, Koen K Van de Vijver, Mariëtte I E van Poelgeest, et al.The Journal of Pathology|April 12, 2022
Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervixSarah H Kim, Thais Basili, Higinio Dopeso, et al.Nature Genetics|June 3, 2020
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapyAlejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager, et al.Pageof 15